Mural Oncology plc (MURA) SEC Filings, Jun-Jul 2025

Mural Oncology plc's SEC filings document material-event disclosures for a former Nasdaq-listed Irish biotechnology issuer, including Forms 8-K reporting operating results, financial condition, material agreements, shareholder voting matters, governance matters, and capital-structure information tied to its ordinary shares.

The filing record also covers corporate-status and transaction disclosures associated with its completed Irish scheme of arrangement and acquisition. These records describe formal shareholder materials, registered security information, exhibit filings, and clinical, regulatory, and operating disclosures relevant to Mural's cytokine-based immunotherapy business history.